<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>endocrinology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>endocrinology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT
Authors: Nelson, L. A.; Spieker, A. J.; Greevy, R. A.; Roddy, M. K.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M.; Aikens, J. E.; Wolever, R. Q.; Elasy, T. A.; Mayberry, L. S.
Score: 1.2, Published: 2023-09-12 DOI: 10.1101/2023.09.11.23295374
AimsFamily/friends Activation to Motivate Self-care (FAMS) is a self-care support intervention delivered via mobile phones.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/endocrinology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="endocrinology" />
<meta property="og:description" content="Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT
Authors: Nelson, L. A.; Spieker, A. J.; Greevy, R. A.; Roddy, M. K.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M.; Aikens, J. E.; Wolever, R. Q.; Elasy, T. A.; Mayberry, L. S.
Score: 1.2, Published: 2023-09-12 DOI: 10.1101/2023.09.11.23295374
AimsFamily/friends Activation to Motivate Self-care (FAMS) is a self-care support intervention delivered via mobile phones." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/endocrinology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-09-27T10:39:11+00:00" />
<meta property="article:modified_time" content="2023-09-27T10:39:11+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="endocrinology"/>
<meta name="twitter:description" content="Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT
Authors: Nelson, L. A.; Spieker, A. J.; Greevy, R. A.; Roddy, M. K.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M.; Aikens, J. E.; Wolever, R. Q.; Elasy, T. A.; Mayberry, L. S.
Score: 1.2, Published: 2023-09-12 DOI: 10.1101/2023.09.11.23295374
AimsFamily/friends Activation to Motivate Self-care (FAMS) is a self-care support intervention delivered via mobile phones."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "endocrinology",
      "item": "https://trxiv.yorks0n.com/posts/endocrinology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "endocrinology",
  "name": "endocrinology",
  "description": "Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT\nAuthors: Nelson, L. A.; Spieker, A. J.; Greevy, R. A.; Roddy, M. K.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M.; Aikens, J. E.; Wolever, R. Q.; Elasy, T. A.; Mayberry, L. S.\nScore: 1.2, Published: 2023-09-12 DOI: 10.1101/2023.09.11.23295374\nAimsFamily/friends Activation to Motivate Self-care (FAMS) is a self-care support intervention delivered via mobile phones.",
  "keywords": [
    
  ],
  "articleBody": " Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT\nAuthors: Nelson, L. A.; Spieker, A. J.; Greevy, R. A.; Roddy, M. K.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M.; Aikens, J. E.; Wolever, R. Q.; Elasy, T. A.; Mayberry, L. S.\nScore: 1.2, Published: 2023-09-12 DOI: 10.1101/2023.09.11.23295374\nAimsFamily/friends Activation to Motivate Self-care (FAMS) is a self-care support intervention delivered via mobile phones. We evaluated FAMS effects on hemoglobin A1c (HbA1c) and intervention targets among adults with type 2 diabetes in a 15-month RCT. MethodsPersons with diabetes (PWDs) and their support persons (family/friend, optional) were randomized to FAMS or control. FAMS included monthly phone coaching and text messages for PWDs, and text messages for support persons over a 9-month intervention period. ResultsPWDs (N=329) were 52% male, 39% from minoritized racial or ethnic groups, with mean HbA1c 8.6{+/-}1.7%. FAMS improved HbA1c among PWDs with a non-cohabitating support person (-0.64%; 95% CI [-1.22%, -0.05%]), but overall effects were not significant. FAMS improved intervention targets including self-efficacy, dietary behavior, and family/friend involvement during the intervention period; these improvements mediated post-intervention HbA1c improvements (total indirect effect -0.27%; 95% CI [-0.49%, -0.09%]) and sustained HbA1c improvements at 12 months (total indirect effect -0.19%; 95% CI [-0.40%, -0.01%]). ConclusionsDespite improvements in most intervention targets, HbA1c improved only among PWDs engaging non-cohabitating support persons suggesting future family interventions should emphasize inclusion of these relationships. Future work should also seek to identify intervention targets that mediate improvements in HbA1c.\nWell-being outcomes of a family-focused intervention for persons with type 2 diabetes and support persons: Main, mediated, and subgroup effects from the FAMS 2.0 RCT\nAuthors: Roddy, M. K.; Spieker, A. J.; Nelson, L. A.; Greevy, R. A.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M. W.; Elasy, T. A.; Aikens, J. E.; Wolever, R. Q.; Mayberry, L. S.\nScore: 1.2, Published: 2023-09-12 DOI: 10.1101/2023.09.11.23295375\nAimsType 2 diabetes self-management occurs within social contexts. We sought to test the effects of Family/friends Activation to Motivate Self-care (FAMS), a self-care support intervention delivered via mobile phones, on psychosocial outcomes for persons with diabetes (PWDs) and their support persons. MethodsPWDs had the option to enroll with a friend/family member as a support person in a 15-month RCT to evaluate FAMS versus enhanced usual care. FAMS included 9-months of monthly phone coaching and text message support for PWDs, and text message support for enrolled support persons. ResultsPWDs (N=329) were 52% male and 39% from minoritized racial or ethnic groups; 50% enrolled with elevated diabetes distress. Support persons (N=294) were 26% male and 33% minoritized racial or ethnic groups. FAMS improved PWDs diabetes distress (d=-0.19) and global well-being (d=0.21) during the intervention, with patterns of larger effects among minoritized groups. Post-intervention and sustained (15-month) improvements were driven by changes in PWDs self-efficacy, self-care behaviors, and autonomy support. Among support persons, FAMS improved helpful involvement without increasing burden or harmful involvement. ConclusionsFAMS improved PWDs psychosocial well-being, with post-intervention and sustained improvements driven by improved self-efficacy, self-care, and autonomy support. Support persons increased helpful involvement without adverse effects.\nSystematic Review of Treatment of Beta-Cell Monogenic Diabetes\nAuthors: Naylor, R. N.; Patel, K. A.; Kettunen, J. L. T.; Männistö, J. M. E.; Stoy, J.; Beltrand, J.; Polak, M.; ADA/EASD PMDI, ; Vilsobll, T.; Greeley, S. A. W.; Hattersley, A. T.; Tuomi, T.\nScore: 1.2, Published: 2023-09-22 DOI: 10.1101/2023.05.12.23289807\nBackgroundBeta-cell monogenic forms of diabetes are the area of diabetes care with the strongest support for precision medicine. We reviewed treatment of hyperglycemia in GCK-related hyperglycemia, HNF1A- HNF4A- and HNF1B-diabetes, Mitochondrial diabetes (MD) due to m.3243A\u003eG variant, 6q24-transient neonatal diabetes (TND) and SLC19A2-diabetes. MethodsSystematic reviews with data from PubMed, MEDLINE and Embase were performed for the different subtypes. Individual and group level data was extracted for glycemic outcomes in individuals with genetically confirmed monogenic diabetes. Results147 studies met inclusion criteria with only six experimental studies and the rest being single case reports or cohort studies. Most studies had moderate or serious risk of bias. For GCK-related hyperglycemia, six studies (N=35) showed no deterioration in HbA1c on discontinuing glucose lowering therapy. A randomized trial (n=18 per group) showed that sulfonylureas (SU) were more effective in HNF1A-diabetes than in type 2 diabetes, and cohort and case studies supported SU effectiveness in lowering HbA1c. Two crossover trials (n=15 and n=16) suggested glinides and GLP-1 receptor agonists might be used in place of SU. Evidence for HNF4A-diabetes was limited. While some patients with HNF1B-diabetes (n=301) and MD (n=250) were treated with oral agents, most were on insulin. There was some support for the use of oral agents after relapse in 6q24-TND, and for thiamine improving glycemic control and reducing insulin requirement in SLC19A2-diabetes (less than half achieved insulin-independency). ConclusionThere is limited evidence to guide the treatment in monogenic diabetes with most studies being non-randomized and small. The data supports: no treatment in GCK-related hyperglycemia; SU for HNF1A-diabetes. Further evidence is needed to examine the optimum treatment in monogenic subtypes.\n",
  "wordCount" : "829",
  "inLanguage": "en",
  "datePublished": "2023-09-27T10:39:11Z",
  "dateModified": "2023-09-27T10:39:11Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/endocrinology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      endocrinology
    </h1>
    <div class="post-meta"><span>updated on September 27, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.11.23295374">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.11.23295374" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.11.23295374">
        <p class="paperTitle">Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.11.23295374" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.11.23295374" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Nelson, L. A.; Spieker, A. J.; Greevy, R. A.; Roddy, M. K.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M.; Aikens, J. E.; Wolever, R. Q.; Elasy, T. A.; Mayberry, L. S.</p>
        <p class="info">Score: 1.2, Published: 2023-09-12 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.11.23295374' target='https://doi.org/10.1101/2023.09.11.23295374'> 10.1101/2023.09.11.23295374</a></p>
        <p class="abstract">AimsFamily/friends Activation to Motivate Self-care (FAMS) is a self-care support intervention delivered via mobile phones. We evaluated FAMS effects on hemoglobin A1c (HbA1c) and intervention targets among adults with type 2 diabetes in a 15-month RCT.

MethodsPersons with diabetes (PWDs) and their support persons (family/friend, optional) were randomized to FAMS or control. FAMS included monthly phone coaching and text messages for PWDs, and text messages for support persons over a 9-month intervention period.

ResultsPWDs (N=329) were 52% male, 39% from minoritized racial or ethnic groups, with mean HbA1c 8.6{&#43;/-}1.7%. FAMS improved HbA1c among PWDs with a non-cohabitating support person (-0.64%; 95% CI [-1.22%, -0.05%]), but overall effects were not significant. FAMS improved intervention targets including self-efficacy, dietary behavior, and family/friend involvement during the intervention period; these improvements mediated post-intervention HbA1c improvements (total indirect effect -0.27%; 95% CI [-0.49%, -0.09%]) and sustained HbA1c improvements at 12 months (total indirect effect -0.19%; 95% CI [-0.40%, -0.01%]).

ConclusionsDespite improvements in most intervention targets, HbA1c improved only among PWDs engaging non-cohabitating support persons suggesting future family interventions should emphasize inclusion of these relationships. Future work should also seek to identify intervention targets that mediate improvements in HbA1c.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.11.23295375">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.11.23295375" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.11.23295375">
        <p class="paperTitle">Well-being outcomes of a family-focused intervention for persons with type 2 diabetes and support persons: Main, mediated, and subgroup effects from the FAMS 2.0 RCT</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.11.23295375" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.11.23295375" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Roddy, M. K.; Spieker, A. J.; Nelson, L. A.; Greevy, R. A.; LeStourgeon, L. M.; Bergner, E. M.; El-Rifai, M. W.; Elasy, T. A.; Aikens, J. E.; Wolever, R. Q.; Mayberry, L. S.</p>
        <p class="info">Score: 1.2, Published: 2023-09-12 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.11.23295375' target='https://doi.org/10.1101/2023.09.11.23295375'> 10.1101/2023.09.11.23295375</a></p>
        <p class="abstract">AimsType 2 diabetes self-management occurs within social contexts. We sought to test the effects of Family/friends Activation to Motivate Self-care (FAMS), a self-care support intervention delivered via mobile phones, on psychosocial outcomes for persons with diabetes (PWDs) and their support persons.

MethodsPWDs had the option to enroll with a friend/family member as a support person in a 15-month RCT to evaluate FAMS versus enhanced usual care. FAMS included 9-months of monthly phone coaching and text message support for PWDs, and text message support for enrolled support persons.

ResultsPWDs (N=329) were 52% male and 39% from minoritized racial or ethnic groups; 50% enrolled with elevated diabetes distress. Support persons (N=294) were 26% male and 33% minoritized racial or ethnic groups. FAMS improved PWDs diabetes distress (d=-0.19) and global well-being (d=0.21) during the intervention, with patterns of larger effects among minoritized groups. Post-intervention and sustained (15-month) improvements were driven by changes in PWDs self-efficacy, self-care behaviors, and autonomy support. Among support persons, FAMS improved helpful involvement without increasing burden or harmful involvement.

ConclusionsFAMS improved PWDs psychosocial well-being, with post-intervention and sustained improvements driven by improved self-efficacy, self-care, and autonomy support. Support persons increased helpful involvement without adverse effects.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.05.12.23289807">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.05.12.23289807" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.05.12.23289807">
        <p class="paperTitle">Systematic Review of Treatment of Beta-Cell Monogenic Diabetes</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.05.12.23289807" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.05.12.23289807" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Naylor, R. N.; Patel, K. A.; Kettunen, J. L. T.; Männistö, J. M. E.; Stoy, J.; Beltrand, J.; Polak, M.; ADA/EASD PMDI,  ; Vilsobll, T.; Greeley, S. A. W.; Hattersley, A. T.; Tuomi, T.</p>
        <p class="info">Score: 1.2, Published: 2023-09-22 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.05.12.23289807' target='https://doi.org/10.1101/2023.05.12.23289807'> 10.1101/2023.05.12.23289807</a></p>
        <p class="abstract">BackgroundBeta-cell monogenic forms of diabetes are the area of diabetes care with the strongest support for precision medicine. We reviewed treatment of hyperglycemia in GCK-related hyperglycemia, HNF1A- HNF4A- and HNF1B-diabetes, Mitochondrial diabetes (MD) due to m.3243A&gt;G variant, 6q24-transient neonatal diabetes (TND) and SLC19A2-diabetes.

MethodsSystematic reviews with data from PubMed, MEDLINE and Embase were performed for the different subtypes. Individual and group level data was extracted for glycemic outcomes in individuals with genetically confirmed monogenic diabetes.

Results147 studies met inclusion criteria with only six experimental studies and the rest being single case reports or cohort studies. Most studies had moderate or serious risk of bias.

For GCK-related hyperglycemia, six studies (N=35) showed no deterioration in HbA1c on discontinuing glucose lowering therapy. A randomized trial (n=18 per group) showed that sulfonylureas (SU) were more effective in HNF1A-diabetes than in type 2 diabetes, and cohort and case studies supported SU effectiveness in lowering HbA1c. Two crossover trials (n=15 and n=16) suggested glinides and GLP-1 receptor agonists might be used in place of SU. Evidence for HNF4A-diabetes was limited. While some patients with HNF1B-diabetes (n=301) and MD (n=250) were treated with oral agents, most were on insulin. There was some support for the use of oral agents after relapse in 6q24-TND, and for thiamine improving glycemic control and reducing insulin requirement in SLC19A2-diabetes (less than half achieved insulin-independency).

ConclusionThere is limited evidence to guide the treatment in monogenic diabetes with most studies being non-randomized and small. The data supports: no treatment in GCK-related hyperglycemia; SU for HNF1A-diabetes. Further evidence is needed to examine the optimum treatment in monogenic subtypes.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
